IQVIA Holdings Inc
IQV
View Detailed Chart
229.280USD
-6.340-2.69%
Market hours （ET）Quotes delayed by 15 min
39.05BMarket Cap
31.26P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.69%
5 Days
-4.09%
1 Month
+0.96%
6 Months
+17.85%
Year to Date
+1.72%
1 Year
+15.76%
View Detailed Chart
TradingKey Stock Score of IQVIA Holdings Inc
Currency: USD Updated: 2026-01-29Key Insights
IQVIA Holdings Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 3 out of 393 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 260.17.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IQVIA Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
IQVIA Holdings Inc Highlights
StrengthsRisks
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 15.40B.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 15.40B.
Fairly Valued
The company’s latest PE is 32.12, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 169.60M shares, decreasing 9.58% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 3.52K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.10.
Analyst Rating
Based on
25
analysts
Buy
Current Rating
260.169
Target Price
+7.94%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
IQVIA Holdings Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
IQVIA Holdings Inc Info
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Ticker SymbolIQV
CompanyIQVIA Holdings Inc
CEOBousbib (Ari)
Websitehttps://ir.iqvia.com/
Related Instruments
+0.11%
-0.52%
+0.24%
+0.41%
+0.46%
+0.42%
-1.01%
-0.62%
+0.59%
-0.48%
-1.06%
+1.74%
+0.52%
+1.19%
+0.02%
+1.41%
+0.37%
0.00%
-0.50%
-0.58%Popular Symbols
256.450
-1.830 (-0.71%)
191.580
-0.930 (-0.48%)
83300.440
-878.510 (-1.04%)
266.710
-11.700 (-4.20%)
2735.300
-68.050 (-2.43%)
425.640
+9.080 (+2.18%)
5034.860
-358.740 (-6.65%)
65.268
+0.030 (+0.05%)
1.189
-0.007 (-0.60%)
154.652
+1.540 (+1.01%)
